Literature DB >> 20807280

Substrate characterization and catheter ablation for monomorphic ventricular tachycardia in patients with apical hypertrophic cardiomyopathy.

Keiichi Inada1, Jens Seiler, Kurt C Roberts-Thomson, Daniel Steven, Jonathan Rosman, Roy M John, Piotr Sobieszczyk, William G Stevenson, Usha B Tedrow.   

Abstract

UNLABELLED: VT Ablation in Apical Hypertrophic Cardiomyopathy.
INTRODUCTION: Monomorphic ventricular tachycardia (VT) is uncommon in apical hypertrophic cardiomyopathy (HCM). The purpose of this study was to define the substrate and role of catheter ablation for VT in apical HCM.
METHODS: Four patients with apical HCM and frequent, drug refractory VT (mean age of 46 ± 10 years, left ventricular [LV] ejection fraction; 54 ± 14%) underwent catheter ablation with the use of electroanatomic mapping. Endocardial mapping was performed in 4 patients and 3 patients underwent epicardial mapping.
RESULTS: In 3 patients, VT was related to areas of scar in the apical LV where maximal apical wall thickness ranged from 14.5 to 17.8 mm, and 2 patients had apical aneurysms. Endocardial and epicardial substrate mapping revealed low voltage (<1.5 mV) scar in both endocardial and epicardial LV in 2 and only in the epicardium in 1 patient. Inducible VT was abolished with a combination of endocardial and epicardial ablation in 2 patients, but was ineffective in the third patient who had intramural reentry that required transcoronary ethanol ablation of an obtuse marginal vessel for abolition. The fourth patient had focal nonsustained repetitive VT from right ventricular outflow tract (RVOT), consistent with idiopathic RVOT-VT, that was successfully ablated. During follow-ups of 3-9 months, all patients remained free from VT.
CONCLUSION: Monomorphic VT in apical HCM can be due to endocardial, epicardial or intramural reentry in areas of apical scar. Epicardial ablation or transcoronary alcohol ablation is required in some cases.
© 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20807280     DOI: 10.1111/j.1540-8167.2010.01875.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  17 in total

1.  Apical hypertrophic cardiomyopathy presenting as recurrent unexplained syncope.

Authors:  Yusuf Kasirye; Janaki Ram Manne; Narendranath Epperla; Sowjanya Bapani; Romel Garcia-Montilla
Journal:  Clin Med Res       Date:  2011-08-04

2.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

3.  A novel, minimally invasive, segmental myocardial infarction with a clear healed infarct borderzone in rabbits.

Authors:  Ohad Ziv; Lorraine Schofield; Emily Lau; Lenny Chaves; Divyang Patel; Paul Jeng; Xuwen Peng; Bum-Rak Choi; Gideon Koren
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-23       Impact factor: 4.733

4.  Outcomes of Catheter Ablation of Ventricular Tachycardia Based on Etiology in Nonischemic Heart Disease: An International Ventricular Tachycardia Ablation Center Collaborative Study.

Authors:  Marmar Vaseghi; Tiffany Y Hu; Roderick Tung; Pasquale Vergara; David S Frankel; Luigi Di Biase; Usha B Tedrow; Jeffrey A Gornbein; Ricky Yu; Nilesh Mathuria; Shiro Nakahara; Wendy S Tzou; William H Sauer; J David Burkhardt; Venkatakrishna N Tholakanahalli; Timm-Michael Dickfeld; J Peter Weiss; T Jared Bunch; Madhu Reddy; David J Callans; Dhanunjaya R Lakkireddy; Andrea Natale; Francis E Marchlinski; William G Stevenson; Paolo Della Bella; Kalyanam Shivkumar
Journal:  JACC Clin Electrophysiol       Date:  2018-07-25

5.  Apical hypertrophic cardiomyopathy.

Authors:  Raymond F Stainback
Journal:  Tex Heart Inst J       Date:  2012

Review 6.  Risk stratification in hypertrophic cardiomyopathy.

Authors:  S Marrakchi; I Kammoun; E Bennour; L Laroussi; S Kachboura
Journal:  Herz       Date:  2018-04-25       Impact factor: 1.443

7.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Sáenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

8.  ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy.

Authors:  Amar Trivedi; Bradley P Knight
Journal:  Arrhythm Electrophysiol Rev       Date:  2016

Review 9.  Catheter ablation for premature ventricular contractions and ventricular tachycardia in patients with heart failure.

Authors:  Saurabh Kumar; William G Stevenson; Roy M John
Journal:  Curr Cardiol Rep       Date:  2014-09       Impact factor: 2.931

Review 10.  Decompensated Heart Failure With Ventricular Arrhythmia: How Useful Is VT Ablation?

Authors:  Gerasimos Dimitropoulos; Georgios Leventogiannis; Joseph De Bono
Journal:  Curr Heart Fail Rep       Date:  2018-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.